Steven Singer is the chair of the Transactional Department, co-chair of the Life Sciences Group and a member of the Technology Transactions and Licensing Practice Group. He is also a member of the firm’s Management Committee. He joined WilmerHale in 1979.
Mr. Singer has focused his practice in the life sciences industry for nearly three decades. He has served as counsel for public and private companies in the life sciences sector, including biotechnology, medical device and pharmaceutical companies. His practice focuses on joint ventures and strategic alliances, corporate and securities laws, public offerings and venture capital transactions.
Mr. Singer has worked with the following public company clients, among others: Achillion, Alnylam, Critical Therapeutics, Curis, Idenix, Infinity, Millennium, Momenta and NitroMed. Representative private company clients include Agios, Aveo, Cerulean, Constellation, Generation Health, Hydra, Metamark Diagnostics, Micell and PTC Therapeutics. Mr. Singer has also worked with pharmaceutical companies, including Becton Dickinson, Bristol Myers Squibb, Novartis and Wyeth.